Advanced Search

Share

Metrics

Español English

Editorial Board

Publish in this journal

Latest issue

Journal Information

Respuestas rápidas

Share

Share

More article options

Visits

Not available

Letter to the Editor

DOI: 10.1016/j.gaceta.2025.102460

Full text access

The opportunity cost of funding new medicines: an attempt to measure the invisible

El coste de oportunidad de financiar nuevos medicamentos: un intento de medir lo invisible

Download PDF

Laura Vallejo-Torresa,

, David J. Vannessb, Mike Pauldenc, Karl Claxtond

a University of Las Palmas de Gran Canaria, Department of Quantitative Methods in Economics and Management, Canary Islands, Spain

b Pennsylvania State University, Department of Health Policy and Administration, University Park, Pennsylvania, United States of America

c University of Alberta, School of Public Health, Edmonton, Alberta, Canada

d University of York, Centre for Health Economics, York, United Kingdom

Article

This article is available in English

The opportunity cost of funding new medicines: an attempt to measure the invisible

Laura Vallejo-Torres, David J. Vanness, Mike Paulden, Karl Claxton

10.1016/j.gaceta.2025.102460

Table of contents

Publish in

Gaceta Sanitaria

El copago farmacéutico en España tras la reforma del año 2012 desde la perspectiva del usuario. ¿Evidencias de inequidad?

Editor's choice

María Victoria Zunzunegui conversando sobre mortalidad en la pandemia con Joan Carles March

María Victoria Zunzunegui conversando sobre mortalidad en la pandemia con Joan Carles March

Gaceta Sanitaria is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Gaceta Sanitaria follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Idiomas

Gaceta Sanitaria